A media briefing from experts from the Infectious Diseases Society of America to discuss recently issued practice guidelines on Paxlovid and interactions with other commonly prescribed medications.
- Paxlovid and drug interactions – common misunderstandings
- Current availability
- Improving equity, access, and infrastructure
- Questions from media
FEATURING:
Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS—Philadelphia, PA
Member—IDSA COVID-19 Treatment and Management Guidelines Expert Panel
Clinical Professor, Temple University
Clinical Specialist, Infectious Diseases, Temple University
Director, PGY2 Residency in Infectious Diseases Pharmacy, Temple University
Melanie Thompson, MD –Atlanta, GA
Co-chair—HIVMA/IDSA HIV Primary Care Guidance Panel
Past Chair—HIVMA
Member, HHS Antiretroviral Guidelines Panel, IAS-USA Antiretroviral Guidelines Panel
Past Principal Investigator, AIDS Research Consortium of Atlanta
Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America
